Amarin Corporation Plc Sponsored ADR Stock

$10.32

1.05% yesterday

Nasdaq, Apr 28, 10:00 pm CET

ISIN

US0231112063

Symbol

AMRN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Amarin Corporation Plc Sponsored ADR Stock price

$10.32

-146.08 93.40% 5Y

Nasdaq, Closing price Mon, Apr 28 2025

-0.11 1.05%

ISIN

US0231112063

Symbol

AMRN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$213.72m
Enterprise Value	$-73.08m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	2.36
EV/Sales (TTM) EV/Sales	-0.32
P/S ratio (TTM) P/S ratio	0.94
P/B ratio (TTM) P/B ratio	0.44
Revenue growth (TTM) Revenue growth	-25.86%
Revenue (TTM) Revenue	$228.51m
EBIT (operating result TTM) EBIT	$-91.56m
Free Cash Flow (TTM) Free Cash Flow	$-31.03m
Cash position	$294.52m
EPS (TTM) EPS	$-3.99
P/E forward	negative
P/S forward	1.22
EV/Sales forward	negative
Short interest	4.43%

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Get Started for Free Today

Amarin Corporation Plc Sponsored ADR Stock Analysis

Unlock Scores for Free

??

2 Analysts have issued a Amarin Corporation Plc Sponsored ADR forecast:

1x Hold

50%

1x Sell

50%

More details on Analyst Estimates Including Price Targets

2 Analysts have issued a Amarin Corporation Plc Sponsored ADR forecast:

Hold

50%

Sell

50%

Analyst Estimates with Stock Price Targets

Financial data from Amarin Corporation Plc Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	229 229	26% 26% 100%
- Direct Costs	150 150	3% 3% 66%
Gross Profit	79 79	52% 52% 34%
- Selling and Administrative Expenses	149 149	24% 24% 65%
- Research and Development Expense	18 18	8% 8% 8%
EBITDA	-89 -89	65% 65% -39%
- Depreciation and Amortization	3.01 3.01	1% 1% 1%
EBIT (Operating Income) EBIT	-92 -92	61% 61% -40%
Net Profit	-82 -82	38% 38% -36%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Amarin Corporation Plc Sponsored ADR Stock News

Neutral

GlobeNewsWire

●

about 14 hours ago

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin's senior management team to discuss its first quarter 2025 results followed by Q&A on Wednesday, May 7th, 2025, at 8:00 a.m. ET.

Neutral

GlobeNewsWire

●

20 days ago

Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

DUBLIN and BRIDGEWATER, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today confirmed that April 11, 2025 will be the effective date for the Company's previously announced Ratio Change on its American Depositary Shares (“ADS”) -- an action in which the Company will effect a ratio change from one (1) ADS representing one (1) ordinary share to a new ratio of one ...

Neutral

GlobeNewsWire

●

22 days ago

Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors

DUBLIN, Ireland and BRIDGEWATER, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Michael Torok, Co-Founder and Managing Director of investment firm JEC Capital Partners, as a member of the Board of Directors, effective immediately.

More Amarin Corporation Plc Sponsored ADR News

Company Profile

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Head office	United Kingdom
CEO	Aaron Berg
Employees	275
Founded	1989
Website	www.amarincorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now